182 related articles for article (PubMed ID: 1586246)
41. The inhibition of protein synthesis by IgG containing anti-ribosome P autoantibodies from systemic lupus erythematosus patients.
Stacey DW; Skelly S; Watson T; Elkon K; Weissbach H; Brot N
Arch Biochem Biophys; 1988 Nov; 267(1):398-403. PubMed ID: 3196035
[TBL] [Abstract][Full Text] [Related]
42. Anti-P autoantibody production requires P1/P2 as immunogens but is not driven by exogenous self-antigen in MRL mice.
Hines JJ; Weissbach H; Brot N; Elkon K
J Immunol; 1991 May; 146(10):3386-95. PubMed ID: 2026870
[TBL] [Abstract][Full Text] [Related]
43. Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region.
Bruner BF; Wynn DM; Reichlin M; Harley JB; James JA
Ann N Y Acad Sci; 2005 Jun; 1051():390-403. PubMed ID: 16126981
[TBL] [Abstract][Full Text] [Related]
44. Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis.
Press J; Palayew K; Laxer RM; Elkon K; Eddy A; Rakoff D; Silverman ED
Arthritis Rheum; 1996 Apr; 39(4):671-6. PubMed ID: 8630119
[TBL] [Abstract][Full Text] [Related]
45. Ribosomal P antibody: 30 years on the road.
Viana VT; Durcan L; Bonfa E; Elkon KB
Lupus; 2017 Apr; 26(5):453-462. PubMed ID: 28394227
[TBL] [Abstract][Full Text] [Related]
46. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens.
Elkon K; Bonfa E; Llovet R; Danho W; Weissbach H; Brot N
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5186-9. PubMed ID: 2455896
[TBL] [Abstract][Full Text] [Related]
47. Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA.
Caponi L; Pegoraro S; Di Bartolo V; Rovero P; Revoltella R; Bombardieri S
J Immunol Methods; 1995 Feb; 179(2):193-202. PubMed ID: 7876567
[TBL] [Abstract][Full Text] [Related]
48. Anti-ribosomal antibodies from lupus patients bind DNA.
Caponi L; Chimenti D; Pratesi F; Migliorini P
Clin Exp Immunol; 2002 Dec; 130(3):541-7. PubMed ID: 12452847
[TBL] [Abstract][Full Text] [Related]
49. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
Velasco M; Losada M; Losada A; Ramirez G
Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
[No Abstract] [Full Text] [Related]
50. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
Diaz Gill GA; Beutner EH; Eisenberg RB
Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
[No Abstract] [Full Text] [Related]
51. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus.
Krippner H; Springer B; Merle S; Pirlet K
Clin Exp Immunol; 1984 Oct; 58(1):49-56. PubMed ID: 6332696
[TBL] [Abstract][Full Text] [Related]
52. Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus.
Muller S; Briand JP; Van Regenmortel MH
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8176-80. PubMed ID: 2847153
[TBL] [Abstract][Full Text] [Related]
53. IgG Fc receptors in sera from patients with rheumatoid arthritis and systemic lupus erythematosus.
Ulvestad E; Matre R; Tønder O
Scand J Rheumatol Suppl; 1988; 75():203-8. PubMed ID: 3238352
[TBL] [Abstract][Full Text] [Related]
54. Clinical significance of antibodies to histones in systemic lupus erythematosus.
Kohda S; Kanayama Y; Okamura M; Amatsu K; Negoro N; Takeda T; Inoue T
J Rheumatol; 1989 Jan; 16(1):24-8. PubMed ID: 2785597
[TBL] [Abstract][Full Text] [Related]
55. Lupus anti-ribosomal P peptide antibodies show limited heterogeneity and are predominantly of the IgG1 and IgG2 subclasses.
Bonfa E; Chu JL; Brot N; Elkon KB
Clin Immunol Immunopathol; 1987 Oct; 45(1):129-38. PubMed ID: 3113787
[TBL] [Abstract][Full Text] [Related]
56. Complement-fixing ability of antinuclear factors. Studies in adult and juvenile rheumatoid arthritis and systemic lupus erythematosus.
Cossio PM; Arana RM; Morteo OG; Hübscher O; Roux EB
Ann Rheum Dis; 1971 Nov; 30(6):640-4. PubMed ID: 5316115
[No Abstract] [Full Text] [Related]
57. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
58. Class specific antinuclear antibodies in systemic lupus erythematosus.
Savitri K; Sehgal S; Datta BN; Chugh KS
Indian J Med Res; 1993 Feb; 98():27-9. PubMed ID: 8495986
[TBL] [Abstract][Full Text] [Related]
59. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus.
Elkon K; Skelly S; Parnassa A; Moller W; Danho W; Weissbach H; Brot N
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7419-23. PubMed ID: 2429305
[TBL] [Abstract][Full Text] [Related]
60. A prospective study on antiribosomal P proteins in two cases of familial lupus and recurrent psychosis.
Derksen RH; van Dam AP; Gmelig Meyling FH; Bijlsma JW; Smeenk RJ
Ann Rheum Dis; 1990 Oct; 49(10):779-82. PubMed ID: 2241267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
